newsfilter
← Latest News
GlobeNewswire·

CytomX Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock

SOUTH SAN FRANCISCO, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (NASDAQ:CTMX), a leader in the field of masked, conditionally activated biologic therapeutics, today announced the pricing of an